Ajovy 225 mg

AJOVY 225 MG is a subcutaneous solution containing fremanezumab, used for migraine prevention. This medication is designed to help reduce the frequency of migraine episodes.

AJOVY 225 MG is primarily used for the preventive treatment of migraines. Fremanezumab, the active ingredient, is a monoclonal antibody that targets a specific protein involved in migraine pathways. This solution is administered subcutaneously and is intended for patients who experience frequent migraine episodes.

Common effects of AJOVY 225 MG may include injection site reactions such as redness, swelling, or itching. Some users might also experience fatigue, nausea, or upper respiratory tract infections. These effects vary among individuals and are not experienced by everyone who uses the medication.

AJOVY 225 MG should be used with caution in patients with a history of hypersensitivity to fremanezumab or any of its components. It is important to follow the prescribed administration guidelines and consult a healthcare provider before use. Proper storage and handling are essential to maintain the medication's efficacy.

AJOVY 225 MG may interact with other medications, particularly those that affect the immune system or are metabolized by similar pathways. It is advisable to inform your healthcare provider about all medications you are currently taking to avoid potential interactions. Alcohol and certain supplements may also influence the effectiveness of fremanezumab.